PRESS RELEASE published on 12/08/2025 at 07:30, 1 month 3 days ago Eight years of research and development – proprietary algorithms enable the strategic scaling of trading capacities Alphawave GmbH concludes an 8-year R&D phase, introducing scalable trading capacities. Proprietary algorithms drive strategic trading. Impressive internal trading results shared Research And Development Trading Capacities Proprietary Algorithms Alphawave GmbH Internal Trading Results
PRESS RELEASE published on 12/08/2025 at 07:05, 1 month 3 days ago Huawei Celebrates Türkiye's Leading Developers and Designers at Istanbul Awards Event Huawei celebrates Türkiye's leading app developers and watch face designers at Istanbul Awards event, reinforcing commitment to innovation and local talent Innovation Türkiye Designers Developers Huawei
PRESS RELEASE published on 12/08/2025 at 07:00, 1 month 3 days ago Xlife Sciences AG Announces Exit of 12 Project Companies to Grupo Landsteiner and the Creation of a Scalable Transcontinental Life Sciences Platform Xlife Sciences AG announces strategic exit of 12 projects to Grupo Landsteiner, forming a transcontinental life sciences platform with a NASDAQ listing in 2026 Life Sciences Nasdaq Listing Xlife Sciences AG Strategic Exit Grupo Landsteiner
PRESS RELEASE published on 12/08/2025 at 07:00, 1 month 3 days ago Helvetia Baloise publishes Pro Forma Financial Information Helvetia Baloise successfully completes merger with Baloise, forming Helvetia Baloise, Switzerland's largest insurer. Pro Forma Financial Information released showing accounting effects Merger Intangible Assets Helvetia Baloise Pro Forma Financial Information IFRS Accounting Adjustments
PRESS RELEASE published on 12/08/2025 at 07:00, 1 month 3 days ago Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership. Expands capabilities for biosimilars with cutting-edge technology Acquisition Biosimilars Sandoz Just-Evotec Biologics EU SAS Continuous-manufacturing Technology
PRESS RELEASE published on 12/08/2025 at 07:00, 1 month 3 days ago Evotec closes sale of Just – Evotec Biologics’ Toulouse site to Sandoz Evotec closes sale of Just - Evotec Biologics' Toulouse site to Sandoz for over US$650m, including technology license fees. Sale improves revenue mix and profit margins Technology Sale Evotec Sandoz Biologics
PRESS RELEASE published on 12/08/2025 at 07:00, 1 month 3 days ago Newron announces the US initiation of its ENIGMA-TRS 2 Phase III global clinical study with evenamide as an add-on therapy for patients with treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals initiates ENIGMA-TRS 2 Phase III global clinical study in US for treatment-resistant schizophrenia with evenamide as add-on therapy. Expecting results by Q4 2026 Newron Pharmaceuticals Evenamide Phase III Treatment-resistant Schizophrenia ENIGMA-TRS 2
PRESS RELEASE published on 12/08/2025 at 04:30, 1 month 3 days ago Family Support Now Make-or-Break for Overseas Postings, New Study Reveals New research from AXA Global Healthcare reveals the importance of family support for international assignees, urging employers to adopt a more holistic approach. The 2025 World of Work Report emphasizes the impact on assignees' wellbeing and success criteria on global placements Employee Wellbeing International Assignments AXA Global Healthcare Family Support Global Mobility
PRESS RELEASE published on 12/07/2025 at 18:00, 1 month 3 days ago IBC Advanced Alloys Reports Results from its 2025 Annual General Meeting IBC Advanced Alloys Corp. announces results of 2025 Annual General Meeting in Centennial, CO. Shareholders re-elected board members and approved key resolutions Board Of Directors Annual General Meeting Shareholders IBC Advanced Alloys Corp. Resolutions
PRESS RELEASE published on 12/07/2025 at 09:00, 1 month 4 days ago Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering Onco-Innovations engages U.S. investment bank for potential Nasdaq cross-listing and equity financing, part of long-term corporate development strategy Equity Financing Nasdaq Investment Bank Onco-Innovations Cross-listing
Published on 01/10/2026 at 05:10, 1 day 4 hours ago Sekur Private Data Ltd. Announces Non-Brokered Private Placement
Published on 01/10/2026 at 00:45, 1 day 8 hours ago Digi Power X Announces Entry into Settlement Agreement
Published on 01/09/2026 at 23:30, 1 day 9 hours ago Matador Technologies Announces Grant of Restricted Share Units to Management Team
Published on 01/09/2026 at 23:10, 1 day 10 hours ago Usha Resources and Totec Resources Provide Supplemental Disclosure for Qualifying Transaction
Published on 01/10/2026 at 21:25, 11 hours 48 minutes ago CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh
Published on 01/10/2026 at 13:05, 20 hours 8 minutes ago SeaVerse Launches World's First AI Native Platform, "All in AI Native" Leads the Forward-Looking Revolution in AI Creation
Published on 01/09/2026 at 21:55, 1 day 11 hours ago Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)
Published on 01/09/2026 at 18:36, 1 day 14 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/09/2026 at 18:19, 1 day 14 hours ago EQS-Adhoc: BayWa AG: Change in the Board of Management of BayWa AG
Published on 01/09/2026 at 18:30, 1 day 14 hours ago H2 2025 half yearly report on the liquidity agreement signed with the Gilbert Dupont brokerage firm
Published on 01/09/2026 at 17:45, 1 day 15 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 01/09/2026 at 17:42, 1 day 15 hours ago Aéroports de Paris SA - Shares and voting rights as of 31 December 2025
Published on 01/08/2026 at 21:00, 2 days 12 hours ago Biannual report on SEB S.A.’S liquidity agreement